Clinical Trial Update: Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma [NA]

View source ↗

Summary

A terminated clinical trial evaluating stem cell radiotherapy with temozolomide for newly diagnosed high-grade glioma has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Brain Tumor
• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Stem Cell Radiotherapy
• Temodar (Temozolomide)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Glioblastoma, Malignant Glioma | NA | Status: TERMINATED | Results posted: 2017-06-05